Literature DB >> 8675236

Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand.

S Néron1, A Pelletier, M C Chevrier, G Monier, R Lemieux, A Darveau.   

Abstract

Engagement of CD40 on resting B cells in the presence of IL-4 triggers B cell proliferation, differentiation and homotypic adhesion. This study was designed to investigate the role of LFA-1/ICAM-1 interactions in homotypic adhesion and proliferation of CD40-activated human B lymphocytes. Freshly isolated B cells were cultured in vitro in the presence of IL-4 and of L cells expressing CD40L, the CD40 ligand. The addition to the culture medium of LFA-1 and ICAM-1 antibodies inhibited homotypic B lymphocyte adhesion. However, these antibodies failed to affect B lymphocyte proliferation and antibody production. These results indicate that aggregation and proliferation are independent events although both induced by CD40 activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675236     DOI: 10.3109/08820139609059292

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  13 in total

1.  Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction.

Authors:  Sonia Néron; Claudia Racine; Annie Roy; Matthieu Guérin
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

2.  The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA.

Authors:  Ryan Soderquist; Alexandre A Pletnev; Alexey V Danilov; Alan Eastman
Journal:  Apoptosis       Date:  2014-01       Impact factor: 4.677

3.  Nuphar alkaloids induce very rapid apoptosis through a novel caspase-dependent but BAX/BAK-independent pathway.

Authors:  David J Mallick; Alexander Korotkov; Hui Li; Jimmy Wu; Alan Eastman
Journal:  Cell Biol Toxicol       Date:  2019-03-02       Impact factor: 6.691

4.  High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells.

Authors:  Sina Oppermann; Jarkko Ylanko; Yonghong Shi; Santosh Hariharan; Christopher C Oakes; Patrick M Brauer; Juan C Zúñiga-Pflücker; Brian Leber; David E Spaner; David W Andrews
Journal:  Blood       Date:  2016-06-13       Impact factor: 22.113

5.  Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction.

Authors:  Jessie F Fecteau; Annie Roy; Sonia Néron
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

6.  Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737.

Authors:  Darcy J P Bates; Alexey V Danilov; Christopher H Lowrey; Alan Eastman
Journal:  Mol Cancer Ther       Date:  2013-05-30       Impact factor: 6.261

7.  Increased secretion of hyperimmune antibodies following lipopolysaccharide stimulation of CD40-activated human B cells in vitro.

Authors:  Nellie Dumont; Eric Aubin; Dominic P Proulx; Réal Lemieux; Renée Bazin
Journal:  Immunology       Date:  2008-09-05       Impact factor: 7.397

8.  Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo.

Authors:  R Soderquist; D J P Bates; A V Danilov; A Eastman
Journal:  Leukemia       Date:  2013-05-03       Impact factor: 11.528

9.  Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytes.

Authors:  Rayelle Itoua Maïga; Guillaume Bonnaure; Josiane Tremblay Rochette; Sonia Néron
Journal:  J Immunol Res       Date:  2014-12-23       Impact factor: 4.818

10.  Large-scale in vitro expansion of polyclonal human switched-memory B lymphocytes.

Authors:  Sonia Néron; Annie Roy; Nellie Dumont
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.